Grace Therapeutics Financial Overview
Grace Therapeutics's market cap is currently $51.84M. The company's EPS TTM is $-0.06; its P/E ratio is -5.73; Grace Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
